TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong
· Delayed Price · Currency is HKD
50.50
+2.70 (5.65%)
Aug 15, 2025, 4:08 PM HKT
HKG:2617 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -274.61 | -343.39 | -251.94 |
Depreciation & Amortization | 6.17 | 7.14 | 8.74 |
Other Amortization | 0.27 | 0.26 | 0.24 |
Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 |
Loss (Gain) From Sale of Investments | -10.65 | -14.09 | -14.28 |
Stock-Based Compensation | 16.39 | 14.78 | 7.01 |
Other Operating Activities | -0.23 | -11.62 | -33.85 |
Change in Inventory | -0.01 | 0.09 | -0.09 |
Change in Accounts Payable | 2.67 | 6.34 | 33.58 |
Change in Unearned Revenue | - | -1.17 | -0.12 |
Change in Other Net Operating Assets | -11.17 | 22.33 | 13.82 |
Operating Cash Flow | -271.18 | -319.33 | -236.89 |
Capital Expenditures | -0.77 | -3.49 | -2.02 |
Sale of Property, Plant & Equipment | 0 | - | 0 |
Sale (Purchase) of Intangibles | - | -8.3 | -7.81 |
Investment in Securities | 349.19 | -178.66 | 221.06 |
Other Investing Activities | - | 3.51 | -2 |
Investing Cash Flow | 348.42 | -186.94 | 209.23 |
Long-Term Debt Repaid | -3.24 | -3.51 | -2.09 |
Net Debt Issued (Repaid) | -3.24 | -3.51 | -2.09 |
Issuance of Common Stock | - | 20 | 240 |
Other Financing Activities | -1.64 | -0.73 | -2.47 |
Financing Cash Flow | -4.87 | 15.76 | 235.44 |
Foreign Exchange Rate Adjustments | 0.51 | 3.2 | 27.52 |
Net Cash Flow | 72.88 | -487.31 | 235.3 |
Free Cash Flow | -271.96 | -322.81 | -238.91 |
Free Cash Flow Margin | - | -27333.78% | -192667.74% |
Free Cash Flow Per Share | -0.71 | -0.85 | -0.66 |
Levered Free Cash Flow | -163.77 | -53.02 | - |
Unlevered Free Cash Flow | -163.65 | -52.87 | - |
Change in Working Capital | -8.52 | 27.59 | 47.19 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.